Skip to search formSkip to main contentSkip to account menu

NM-3

An orally bioavailable antiangiogenic isocoumarin with potential antineoplastic activity. NM-3 inhibits vascular endothelial growth factor (VEGF), a… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.
AIM To investigate the synergistic effect of oxymatrine (OM) and angiogenesis inhibitor NM-3 on modulating apoptosis in human… 
2007
2007
Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model.
AIM To explore the molecular mechanisms of action of paclitaxel and NM-3 on human gastric cancer in severe combined immune… 
2006
2006
The Effect of NM-3 on Cells Proliferation and Apoptosis of the Human Gastric Cancer Cell SGC-7901 in vitro
Objective: To study the action of NM3, which is a kind of angiogenesis inhibitor, on the growth and apoptosis of human gastric… 
2004
2004
Hydrodynamic Modeling for Micro and Nanoscale Gas Flows
Understanding gas transport characteristics in micro and nanoscale geometries is critical in a variety of gas storage and sensors… 
2003
2003
Formal synthesis of angiogenesis inhibitor NM-3.
We report the formal synthesis of angiogenesis inhibitor NM-3 (1) in six steps from either of the 2,4-dimethoxyhalobenzenes 13a,b… 
2003
2003
Molecule action mechanisms of NM-3 on human gastric cancer SGC-7901 cells in vivo or in vitro.
AIM To study the molecule action mechanisms of NM-3 on the growth of human gastric cancer SGC-7901 cells in vivo or in vitro… 
2003
2003
Convenient total synthesis of NM-3, an antiangiogenesis agent, and its optical resolution.
2002
2002
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
Antiangiogenic therapy, although effective in shrinking tumors, has not yet been established as a standalone treatment for cancer… 
2001
2001
The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species.
2-(8-Hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) is an isocoumarin derivative that has recently entered… 
2000
2000
Suppression of type II collagen-induced arthritis by a new isocoumarin, NM-3.
The anti-arthritic effect of NM-3, a new isocoumarin, was examined using a type II collagen-induced arthritis model for human… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)